Skip to main content
. 2022 Aug 2;27(15):4926. doi: 10.3390/molecules27154926

Figure 10.

Figure 10

The scheme of the study. The baseline reading was collected on day0. The induction phase was started with administration of 2 mg/kg of PTX on day 1 and was continued on alternative days until day 7. After one week, the behavioral studies were conducted to confirm the development of neuropathy. At the same time, treatment was started and was continued until day 21.